Buprenorphine: A Better Option for Opioid Use Disorder Treatment in Pregnancy Compared to Methadone.

IF 2.4 3区医学 Q1 MEDICINE, GENERAL & INTERNAL

Journal of the American Board of Family Medicine Pub Date : 2025-01-01 DOI:10.3122/jabfm.2024.240349R0

Bailey Sanford, Alejandra Espinoza, Kehinde Eniola

引用次数: 0

Abstract

Buprenorphine, rather than methadone, should be considered the preferred first-line therapy for opioid use disorder in pregnancy due to its more favorable neonatal outcomes.¹.

查看原文本刊更多论文

丁丙诺啡：与美沙酮相比，妊娠期阿片类药物使用障碍治疗的更好选择。

丁丙诺啡，而不是美沙酮，应被视为首选一线治疗阿片类药物使用障碍的妊娠，因为其更有利的新生儿结局。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of the American Board of Family Medicine 医学-医学：内科

CiteScore

4.90

自引率

6.90%

发文量

168

审稿时长

4-8 weeks

期刊介绍： Published since 1988, the Journal of the American Board of Family Medicine ( JABFM ) is the official peer-reviewed journal of the American Board of Family Medicine (ABFM). Believing that the public and scientific communities are best served by open access to information, JABFM makes its articles available free of charge and without registration at www.jabfm.org. JABFM is indexed by Medline, Index Medicus, and other services.